Arimidex Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

Roll-over Study to Allow Continued Access to Ribociclib
Condition:   Metastatic Breast Cancer Interventions:   Drug: Ribociclib;   Drug: Letrozole;   Drug: Anastrozole;   Drug: Goserelin;   Drug: Tamoxifen;   Drug: Fulvestrant Sponsor:   Novartis Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 17, 2021 Category: Research Source Type: clinical trials